Risk of skin cancer among patients with chronic kidney disease treated with ultraviolet b phototherapy for uraemic pruritus: A nationwide cohort study

  • Mei Ju Ko
  • , Jenq Wen Huang
  • , Hon Yen Wu
  • , Wan Chuan Tsai
  • , Le Yin Hsu
  • , Ping Hsiu Tsai
  • , Kuo Liong Chien
  • , Kuan Yu Hung

研究成果: 雜誌貢獻文章同行評審

12 引文 斯高帕斯(Scopus)

摘要

The safety of ultraviolet B (UVB) phototherapy with respect to cutaneous carcinogenesis has not been established for patients with chronic kidney disease. To investigate this issue, a nationwide cohort study of 10,805 patients with advanced chronic kidney disease was conducted using data from the National Health Insurance of Taiwan, the Taiwan Cancer Registry, and the national death registry. After a median follow-up of 75 months, 16 of 2,161 patients in the UVB group and 63 of 8,644 patients in the non-UVB group developed skin cancers. Compared with the non-UVB group, patients in the UVB group did not show an increased risk of skin cancer (hazard ratio 1.066; 95% confidence interval 0.584–1.944), non-melanoma skin cancer (hazard ratio 1.067; 95% confidence interval 0.571–1.996), or cutaneous melanoma (hazard ratio 1.009; 95% confidence interval 0.115–8.879). In addition, patients who received more UVB phototherapy did not show an increased risk of skin cancer. UVB phototherapy appears to be a safe treatment for uraemic pruritus in patients with chronic kidney disease.
原文英語
文章編號adv00390
頁(從 - 到)1-6
頁數6
期刊Acta Dermato-Venereologica
101
發行號2
DOIs
出版狀態已發佈 - 2021
對外發佈

ASJC Scopus subject areas

  • 皮膚科

指紋

深入研究「Risk of skin cancer among patients with chronic kidney disease treated with ultraviolet b phototherapy for uraemic pruritus: A nationwide cohort study」主題。共同形成了獨特的指紋。

引用此